Showing results (71-80 of 110) with videos related to
Sort By:
Pageof 11
Journal of Alzheimer'S Disease : JAD|November 14, 2014
Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1/BVR-a system: insights for transition to Alzheimer's diseaseFabio Di Domenico, Gilda Pupo, Cesare Mancuso, et al.Proteomics. Clinical Applications|March 2, 2011
Oxidative stress occurs early in Down syndrome pregnancy: A redox proteomics analysis of amniotic fluidMarzia Perluigi, Fabio di Domenico, Ada Fiorini, et al.Free Radical Biology & Medicine|December 27, 2025
Systemic administration of the OGT inhibitor OSMI-1 normalizes hippocampal O-GlcNAcylation and improves recognition memory, redox balance, and brain mitochondrial homeostasis in a Rett syndrome mouse modelChiara Sette, Chiara Urbinati, Chiara Lanzillotta, et al.Journal of Clinical Medicine|June 5, 2020
The Anti-Diabetic Drug Metformin Rescues Aberrant Mitochondrial Activity and Restrains Oxidative Stress in a Female Mouse Model of Rett SyndromeIlaria Zuliani, Chiara Urbinati, Daniela Valenti, et al.Antioxidants & Redox Signaling|September 15, 2016
Polyubiquitinylation Profile in Down Syndrome Brain Before and After the Development of Alzheimer NeuropathologyAntonella Tramutola, Fabio Di Domenico, Eugenio Barone, et al.Antioxidants & Redox Signaling|January 11, 2012
Lack of p53 decreases basal oxidative stress levels in the brain through upregulation of thioredoxin-1, biliverdin reductase-A, manganese superoxide dismutase, and nuclear factor kappa-BEugenio Barone, Giovanna Cenini, Rukhsana Sultana, et al.Proteome Science|March 20, 2010
Effects of UVB-induced oxidative stress on protein expression and specific protein oxidation in normal human epithelial keratinocytes: a proteomic approachMarzia Perluigi, Fabio Di Domenico, Carla Blarzino, et al.Free Radical Biology & Medicine|March 14, 2022
CAPE and its synthetic derivative VP961 restore BACH1/NRF2 axis in Down SyndromeSara Pagnotta, Antonella Tramutola, Eugenio Barone, et al.Antioxidants (Basel, Switzerland)|January 21, 2023
Intranasal Administration of KYCCSRK Peptide Rescues Brain Insulin Signaling Activation and Reduces Alzheimer's Disease-like Neuropathology in a Mouse Model for Down SyndromeAntonella Tramutola, Simona Lanzillotta, Giuseppe Aceto, et al.The American Journal of Cardiology|April 9, 2013
Usefulness of preprocedural levels of advanced glycation end products to predict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris (from the Prospective ARMYDA-AGEs Study)Cristiano Spadaccio, Giuseppe Patti, Federico De Marco, et al.Pageof 11